The European approach to hepatocellular carcinoma

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Patients with cirrhosis of viral, metabolic or autoimmune origin are at high risk of developing hepatocellular carcinoma. Prospective surveillance based on semi-annual ultrasound examination of the abdomen has allowed for detection of small tumors in many patients, but it is not clear whether liver-related mortality was decreased in parallel. Prognostication in patients with hepatocellular carcinoma requires integrated assessment of tumor size and number, liver function and performance status. The therapeutic approach is to a large extent non-evidence based and the best treatment choice depends on individual patients characteristics, taking into account the local technological and therapeutic resources and skills. Since surgical resection, liver transplantation and percutaneous ablation have achieved a high rate of complete response in properly selected patients, these procedures are considered curative treatments. Being curative treatments applicable only to patients with a small tumor, hepatocellular carcinoma surveillance aimed at early detection of the tumor is the most practical approach for improving treatment outcome.

Original languageEnglish
Pages (from-to)12-16
Number of pages5
JournalHepato-Gastroenterology
Volume49
Issue number43
Publication statusPublished - 2002

Fingerprint

Hepatocellular Carcinoma
Neoplasms
Therapeutics
Liver
Liver Transplantation
Abdomen
Fibrosis
Mortality

Keywords

  • Cirrhosis
  • Hepatocellular carcinoma
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The European approach to hepatocellular carcinoma. / Colombo, Massimo; Sangiovanni, Angelo.

In: Hepato-Gastroenterology, Vol. 49, No. 43, 2002, p. 12-16.

Research output: Contribution to journalArticle

@article{3dcff39c396a49b784b7a616edd18cc9,
title = "The European approach to hepatocellular carcinoma",
abstract = "Patients with cirrhosis of viral, metabolic or autoimmune origin are at high risk of developing hepatocellular carcinoma. Prospective surveillance based on semi-annual ultrasound examination of the abdomen has allowed for detection of small tumors in many patients, but it is not clear whether liver-related mortality was decreased in parallel. Prognostication in patients with hepatocellular carcinoma requires integrated assessment of tumor size and number, liver function and performance status. The therapeutic approach is to a large extent non-evidence based and the best treatment choice depends on individual patients characteristics, taking into account the local technological and therapeutic resources and skills. Since surgical resection, liver transplantation and percutaneous ablation have achieved a high rate of complete response in properly selected patients, these procedures are considered curative treatments. Being curative treatments applicable only to patients with a small tumor, hepatocellular carcinoma surveillance aimed at early detection of the tumor is the most practical approach for improving treatment outcome.",
keywords = "Cirrhosis, Hepatocellular carcinoma, Treatment",
author = "Massimo Colombo and Angelo Sangiovanni",
year = "2002",
language = "English",
volume = "49",
pages = "12--16",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "43",

}

TY - JOUR

T1 - The European approach to hepatocellular carcinoma

AU - Colombo, Massimo

AU - Sangiovanni, Angelo

PY - 2002

Y1 - 2002

N2 - Patients with cirrhosis of viral, metabolic or autoimmune origin are at high risk of developing hepatocellular carcinoma. Prospective surveillance based on semi-annual ultrasound examination of the abdomen has allowed for detection of small tumors in many patients, but it is not clear whether liver-related mortality was decreased in parallel. Prognostication in patients with hepatocellular carcinoma requires integrated assessment of tumor size and number, liver function and performance status. The therapeutic approach is to a large extent non-evidence based and the best treatment choice depends on individual patients characteristics, taking into account the local technological and therapeutic resources and skills. Since surgical resection, liver transplantation and percutaneous ablation have achieved a high rate of complete response in properly selected patients, these procedures are considered curative treatments. Being curative treatments applicable only to patients with a small tumor, hepatocellular carcinoma surveillance aimed at early detection of the tumor is the most practical approach for improving treatment outcome.

AB - Patients with cirrhosis of viral, metabolic or autoimmune origin are at high risk of developing hepatocellular carcinoma. Prospective surveillance based on semi-annual ultrasound examination of the abdomen has allowed for detection of small tumors in many patients, but it is not clear whether liver-related mortality was decreased in parallel. Prognostication in patients with hepatocellular carcinoma requires integrated assessment of tumor size and number, liver function and performance status. The therapeutic approach is to a large extent non-evidence based and the best treatment choice depends on individual patients characteristics, taking into account the local technological and therapeutic resources and skills. Since surgical resection, liver transplantation and percutaneous ablation have achieved a high rate of complete response in properly selected patients, these procedures are considered curative treatments. Being curative treatments applicable only to patients with a small tumor, hepatocellular carcinoma surveillance aimed at early detection of the tumor is the most practical approach for improving treatment outcome.

KW - Cirrhosis

KW - Hepatocellular carcinoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0036215352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036215352&partnerID=8YFLogxK

M3 - Article

C2 - 11941934

AN - SCOPUS:0036215352

VL - 49

SP - 12

EP - 16

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 43

ER -